Pharmaceutical Statistics

Papers
(The H4-Index of Pharmaceutical Statistics is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The use of external controls: To what extent can it currently be recommended?43
Principal stratum strategy: Potential role in drug development40
Win statistics (win ratio, win odds, and net benefit) can complement one another to show the strength of the treatment effect on time‐to‐event outcomes23
Joint hypothesis testing of the area under the receiver operating characteristic curve and the Youden index21
Adjusting win statistics for dependent censoring20
Assessing efficacy in important subgroups in confirmatory trials: An example using Bayesian dynamic borrowing17
How to choose a time zero for patients in external control arms17
Estimating and comparing adverse event probabilities in the presence of varying follow‐up times and competing events16
Standard and reference‐based conditional mean imputation16
Non‐proportional hazards in immuno‐oncology: Is an old perspective needed?15
TITE‐gBOIN: Time‐to‐event Bayesian optimal interval design to accelerate dose‐finding accounting for toxicity grades13
Estimands in observational studies: Some considerations beyondICH E9(R1)13
Decision rules for identifying combination therapies in open‐entry, randomized controlled platform trials12
Sample size calculations for single‐arm survival studies using transformations of the Kaplan–Meier estimator12
A novel equivalence probability weighted power prior for using historical control data in an adaptive clinical trial design: A comparison to standard methods12
Incorporating historical information to improve phase I clinical trials12
0.039673805236816